| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/06/2004 | CN1169555C Decocted pill medicine for treating excess syndrome of hepatitis B |
| 10/06/2004 | CN1169531C Process for producing freezed dried centipede |
| 10/06/2004 | CN1169529C Nano silver antimicrobial inflammation-relieving gel for curing prostatitis and its industrial production process |
| 10/06/2004 | CN1169514C Use of compound for improving skin and its mucous membrane physical-chemical property to prevent adsorption of microorganism |
| 10/05/2004 | US6800745 For microbiocides |
| 10/05/2004 | US6800735 Interferon-beta fusion proteins and uses |
| 10/05/2004 | US6800734 Membrane proteins, such as kinase, permease, mannosyltransferase and endoflagellin used to induce a protective immune response in animals; vaccines |
| 10/05/2004 | US6800727 Peptides with increased + charge and hydrophobicity by substituting one or more amino acids of CA-MA peptide and pharmaceutical compositions containing thereof |
| 10/05/2004 | US6800656 Tricyclic compounds and method of treating herpes virus |
| 10/05/2004 | US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 10/05/2004 | US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 10/05/2004 | US6800629 Pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof |
| 10/05/2004 | US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc. |
| 10/05/2004 | US6800624 Sulfonamide and sulfamide substituted imidazoquinolines |
| 10/05/2004 | US6800621 Imidazo[4,5-b]-pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum activity |
| 10/05/2004 | US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | US6800613 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 10/05/2004 | US6800434 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 10/05/2004 | US6800305 Pharmaceutical composition that contains eucalyptus and orange oil |
| 10/05/2004 | US6800290 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |
| 10/05/2004 | US6800288 Recombinant ns gene of influenza a virus comprising a functional rna binding domain and a sequence modification of the ns1 gene segment which bars transcription of the remaining portion of that segment; vaccines |
| 10/05/2004 | CA2103837C Novel method of producing 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 10/05/2004 | CA2103836C 7-(substituted)-9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 10/05/2004 | CA2090561C Pulsatile once-a-day-delivery systems for minocycline |
| 09/30/2004 | WO2004083426A1 Novel antisense oligonucleotide and anti-hiv agent |
| 09/30/2004 | WO2004083251A2 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| 09/30/2004 | WO2004083227A1 Isopropanolate of azithromycin and method of manufacturing |
| 09/30/2004 | WO2004083207A1 Naphthyridine derivatives as antibacterial agents |
| 09/30/2004 | WO2004083206A1 Antibacterial oxalidinones |
| 09/30/2004 | WO2004083200A1 Crystalline form of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 09/30/2004 | WO2004083188A1 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 09/30/2004 | WO2004083186A1 Therapeutic agent for viral hepatitis and carcinostatic agent |
| 09/30/2004 | WO2004083172A2 Process for the preparation of 7-amino (p-hydroxyphenylglyclyamido) cephem compounds |
| 09/30/2004 | WO2004083167A1 Sulfamide derivative and medicinal composition thereof |
| 09/30/2004 | WO2004082701A1 New engineered antibiotic peptide and its preparing process |
| 09/30/2004 | WO2004082671A1 Anti-microbially active diamine-based guanine derivatives |
| 09/30/2004 | WO2004082669A2 Antiflatulents in combibation with histamine h1-receptor antagonist for treating gastrointestinal disoders |
| 09/30/2004 | WO2004082586A2 Phamaceutical compositions comprising inhibitors of fab i and further antibiotics |
| 09/30/2004 | WO2004064912A8 An otorhinological delivery device |
| 09/30/2004 | WO2004047725A3 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 09/30/2004 | WO2004041209A3 Transcription factor modulating compounds and methods of use thereof |
| 09/30/2004 | WO2004029092A3 Antibody for adcc and inducing cytokine production |
| 09/30/2004 | WO2004028564A3 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 09/30/2004 | WO2004016632A8 Lincomycin derivatives possessing antibacterial activity |
| 09/30/2004 | WO2003088903A3 Compounds, compositions, and methods |
| 09/30/2004 | WO2003073097A3 Methods for isolating ligands e.g. t cell epitopes |
| 09/30/2004 | WO2003068197A8 Method for systemic drug delivery through the nail |
| 09/30/2004 | WO2003062447A3 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 09/30/2004 | WO2003049703A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 09/30/2004 | US20040194159 Cloning pigs using donor nuclei from differentiated cells |
| 09/30/2004 | US20040192943 Nf-kappab inhibitors |
| 09/30/2004 | US20040192928 Reduce skin sensitivity; dissolving 4,5-diphenylimidazole in aprotic solvent; mixing with base and alkyl halide; heating |
| 09/30/2004 | US20040192922 Novel azole or triazole derivatives, method for preparing the same and use thereof as antifungal medicaments |
| 09/30/2004 | US20040192904 Process for the preparation of ribavirin |
| 09/30/2004 | US20040192903 Comprises chromosomal regoin which codes pathogenicity islands (PAIs) for use in developing antibodies to detect and prevent bacterial infection; bactericides |
| 09/30/2004 | US20040192752 Anti-HIV pyrazole derivatives |
| 09/30/2004 | US20040192733 Hydroxamic acid derivatives |
| 09/30/2004 | US20040192719 Peptide deformylase inhibitors |
| 09/30/2004 | US20040192717 Salts of guanidine derivatives and pharmaceutical preparations consisting thereof |
| 09/30/2004 | US20040192709 7-oxo-pyridopyrimidines (II) |
| 09/30/2004 | US20040192707 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 09/30/2004 | US20040192704 Non-nucleoside reverse transcriptase inhibitors |
| 09/30/2004 | US20040192701 Phenlypyridine carbonyl piperazine derivative |
| 09/30/2004 | US20040192700 Heating in solvent; controlling temperature; cooling; isolation; drying |
| 09/30/2004 | US20040192687 Dna-pk inhibitors |
| 09/30/2004 | US20040192666 Nonnucleoside reverse transcriptase inhibitors |
| 09/30/2004 | US20040192651 substituted cyclic phosphate diesters of 1-aryl-1,3-propane diols, that have the trans-stereochemistry and their use to synthesize phosphate prodrugs that have the cis-configuration; use of these trans-phosphorylating reagents for the stereoselective synthesis of cis-phosphate prodrugs |
| 09/30/2004 | US20040192642 Prevention of urogenital infections |
| 09/30/2004 | US20040192606 treating an infection or ischemic wound in a mammal by administering relaxin; treating ischemic ulcer with recombinant human relaxin (H2) for example |
| 09/30/2004 | US20040192589 Production of high molecular mass lectins |
| 09/30/2004 | US20040192579 Administration of the mammal a formulation containing a matrine component and dictamnine in amount effective to deliver daily amount of at least 15 mu mole of a matrine component and at least 0.15 mu mole of dictamnine/kg of body weight to treat cancer |
| 09/30/2004 | US20040191866 Attenuated microorganisms for the treatment of infection |
| 09/30/2004 | US20040191840 Using immunoglobulins to inactivate viricidal and antitumor activities of huma n type interferon for preventing autoimmunity and graft rejection; immunosuppressants |
| 09/30/2004 | US20040191826 Dipeptidyl peptidases |
| 09/30/2004 | US20040191767 Comprises nucleotide sequences coding hepatitis core protein fusion for generating vaccine to prevent infcetion and treat liver dysfunction; gene therapy and cell-mediated immune response |
| 09/30/2004 | US20040191311 Use of methyltestosterone as a drug for treatment of human papilloma virus infections |
| 09/30/2004 | US20040191310 Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases |
| 09/30/2004 | US20040191295 Preventing rotavirus induced diarrhea; lactulose |
| 09/30/2004 | US20040191272 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 09/30/2004 | US20040191270 Vaccine compositions |
| 09/30/2004 | US20040191263 Enteral compositions for the prevention and/or treatment of sepsis |
| 09/30/2004 | US20040191242 Method for producing a vaccine |
| 09/30/2004 | US20040191239 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 09/30/2004 | US20040191236 Administering antigen associated with disease, a dendritic cell binding agent specific for the antigen, and an autologous dendritic cell; immunotherapy |
| 09/30/2004 | US20040191234 Administering prebiotic such as fructo-oligosaccharide; measles prevention; vaccines; nutrients |
| 09/30/2004 | US20040191219 HSA-free formulations of interferon-beta |
| 09/30/2004 | US20040191216 Medicines including interferon and administering system thereof |
| 09/30/2004 | US20040191214 Nucleoside vaccine adjuvants |
| 09/30/2004 | US20040191185 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration |
| 09/30/2004 | US20040191184 Delivery of muscle relaxants through an inhalation route |
| 09/30/2004 | US20040191183 Delivery of antiemetics through an inhalation route |
| 09/30/2004 | US20040191182 Delivery of analgesics through an inhalation route |
| 09/30/2004 | US20040191181 Vaporization of diphenhydramine from solid for breathing administerig |
| 09/30/2004 | US20040191180 Breathing analgesics after vaporization for administering pain killer for headaches |
| 09/30/2004 | US20040191179 Breathing antidepressants from aerosols for administering bupropion by heating on a solid support |
| 09/30/2004 | CA2519853A1 Process for the preparation of 7-amino (p-hydroxyphenylglycylamido) cephem compounds |
| 09/30/2004 | CA2519511A1 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| 09/30/2004 | CA2519439A1 Compositions and methods for treating colic |
| 09/30/2004 | CA2519429A1 Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics |